Depression and cardiovascular comorbidity.
Depression has long had a popular link to cardiovascular disease and death. However, only during the last 15 years has scientific evidence supporting this common wisdom been available. Beginning in the early 1990s, there began to accumulate community-based epidemiological evidence that medically healthy, depressed patients followed for long periods of time were at increased risk of both cardiovascular disease and cardiac death. In the mid-1990s, evidence appeared to indicate that depression following a heart attack increased the risk of death. It is now apparent that depression aggravates the course of multiple cardiovascular conditions. There are two major unanswered questions. One is whether treating depression will reduce the risk of cardiovascular disease and death. Here, preliminary, but not definitive, evidence suggests that the serotonin reuptake inhibitors may be useful. The other unanswered question regards the mechanisms that underlie this link between depression and cardiovascular disease. There is strong evidence linking platelet activation, autonomic activity and inflammatory markers to both depression and heart disease, but why these links exist is far less clear.
Glassman
Alexander H
AH
Columbia University, New York, NY, USA. ahg1@columbia.edu
D001341:Autonomic Nervous System / Q000503:physiopathology; D015415:Biomarkers / Q000032:analysis / Q000097:blood; D002318:Cardiovascular Diseases / Q000401:mortality* / Q000503:physiopathology / Q000523:psychology*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D015897:Comorbidity; D003866:Depressive Disorder / Q000188:drug therapy / Q000401:mortality* / Q000503:physiopathology*; D006801:Humans; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology / Q000627:therapeutic use
D015415:Biomarkers; D017367:Selective Serotonin Reuptake Inhibitors